NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)

See the published facts, notice history, awards and supplier links in one place. Open the original Contracts Finder notice for the full record.

View record reference

ocds-b5fd17-5bdeb37b-fea5-437d-9dc4-a1415f3c6f1c

Published facts

What the notice says

Buyer: NHS England
Published status: complete
Latest release reference: 5b2ed894-865e-46a1-9251-f9f8b92b6a85-737287
CPV codes: Common Procurement Vocabulary (CPV) codes: 33600000
Published tags: award
Latest record Bidwake loaded from this source: 27 Aug 2026

NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5) Tender Reference: CM/PHR/22/5686/01 Period of framework agreement: 1 April 2024 to 31 March 2028 (covering regions East of England, London, North of England and South East).

Open the official Contracts Finder notice

Observed notice trail

How the published record developed

Events follow the publisher date where one is available. “Seen by Bidwake” is the date this service first found the record.

Award notice observed
3 Apr 2024
Latest variant observed by Bidwake on 20 Aug 2026.
Open this official Contracts Finder notice
Record references
Release reference
5b2ed894-865e-46a1-9251-f9f8b92b6a85-737287
Published tags
award

Awards and suppliers

Published award and contract facts

NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)
Buyer: NHS EnglandSupplier: Baxter Healthcare Ltd
End date in notice
31 Mar 2028
Value shown in notice
£608,000,000Whole award value; not assigned to one supplier
Official source
Open the official Contracts Finder notice for NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)
About this figure
- This award names more than one supplier but does not divide the published value between them. The figure is shown for context and is not assigned to one supplier.
View record references
Source
Contracts Finder
Award or lot reference
ocds-b5fd17-5bdeb37b-fea5-437d-9dc4-a1415f3c6f1c-1
NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)
Buyer:

How to read the dates and links

End dates, recurrence wording and links are shown as they appear in public notices. They do not create a new opportunity. If no later linked record appears here, that means Bidwake did not find one in the records it has loaded; it does not prove that none exists.

What the notice says

How the published record developed

3 Apr 2024

Published award and contract facts